STOCK TITAN

Sysorex Financials

SYSX
Source SEC Filings (10-K/10-Q) Updated Jun 30, 2023 Currency USD FYE December

This page shows Sysorex (SYSX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 40 / 100
Financial Profile 40/100

Based on FY2022 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Sysorex's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Sysorex has an operating margin of -42.0%, meaning the company retains $-42 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -127.5% the prior year.

Growth
71

Sysorex's revenue surged 108.6% year-over-year to $17.3M, reflecting rapid business expansion. This strong growth earns a score of 71/100.

Leverage
100

Sysorex carries a low D/E ratio of -1.83, meaning only $-1.83 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
2

Sysorex's current ratio of 0.37 is below the typical benchmark, resulting in a score of 2/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Neutral
4/9

Sysorex passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.62x

For every $1 of reported earnings, Sysorex generates $0.62 in operating cash flow (-$7.5M OCF vs -$12.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-51.9x

Sysorex earns $-51.9 in operating income for every $1 of interest expense (-$7.3M vs $140K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$17.3M
YoY+108.6%
5Y CAGR-15.9%

Sysorex generated $17.3M in revenue in fiscal year 2022. This represents an increase of 108.6% from the prior year.

EBITDA
-$6.7M
YoY+34.2%

Sysorex's EBITDA was -$6.7M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 34.2% from the prior year.

Net Income
-$12.2M
YoY+75.2%

Sysorex reported -$12.2M in net income in fiscal year 2022. This represents an increase of 75.2% from the prior year.

EPS (Diluted)
$-0.01

Sysorex earned $-0.01 per diluted share (EPS) in fiscal year 2022. This represents an increase of 97.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$29K
YoY-95.6%
5Y CAGR+5.7%

Sysorex held $29K in cash against $0 in long-term debt as of fiscal year 2022.

Dividends Per Share
N/A
Shares Outstanding
2M

Sysorex had 2M shares outstanding in fiscal year 2022. This represents a decrease of 98.3% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
-42.0%
YoY+85.5pp
5Y CAGR-6.9pp

Sysorex's operating margin was -42.0% in fiscal year 2022, reflecting core business profitability. This is up 85.5 percentage points from the prior year.

Net Margin
-70.4%
YoY+521.5pp
5Y CAGR-29.4pp

Sysorex's net profit margin was -70.4% in fiscal year 2022, showing the share of revenue converted to profit. This is up 521.5 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

SYSX Income Statement

Metric Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21 Q3'21
Revenue $1.6M-60.0% $4.1M-22.6% $5.3M+52.7% $3.5M-2.2% $3.5M-29.8% $5.0M+67.0% $3.0M+61.6% $1.9M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A $1.9M
Gross Profit N/A N/A N/A N/A N/A N/A N/A -$34K
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $2.7M+13.7% $2.4M+51.3% $1.6M+14.9% $1.4M-15.1% $1.6M-54.7% $3.6M-61.8% $9.3M+9250.0% $100K
Operating Income -$2.7M-20.5% -$2.3M-375.3% -$478K+64.7% -$1.4M+52.6% -$2.9M-10.4% -$2.6M-24.3% -$2.1M+44.9% -$3.8M
Interest Expense -$678K-3.8% -$653K+2.5% -$670K-211.7% $600K+178.5% -$764K-178.4% $974K-24.0% $1.3M+540.5% $200K
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$3.9M-109.9% -$1.9M-71.1% -$1.1M-2.0% -$1.1M+84.7% -$7.0M-130.7% -$3.0M+84.8% -$19.9M-323.3% -$4.7M
EPS (Diluted) $-1.53-382400.0% $-0.00 N/A $0.00 $-14.00-66566.7% $-0.02 N/A $-0.04

SYSX Balance Sheet

Metric Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21 Q3'21
Total Assets $7.4M-33.8% $11.2M-15.2% $13.2M-9.4% $14.6M-18.8% $18.0M-12.9% $20.7M-18.2% $25.3M-4.6% $26.5M
Current Assets $5.3M-40.4% $9.0M-16.9% $10.8M N/A N/A $10.8M-47.0% $20.4M+137.6% $8.6M
Cash & Equivalents $289K+118.9% $132K+355.2% $29K-79.4% $141K-62.1% $372K-60.3% $938K+42.3% $659K-84.6% $4.3M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $558K-81.2% $3.0M-26.6% $4.1M+338.5% $924K-58.1% $2.2M+42.0% $1.6M-48.6% $3.0M N/A
Goodwill N/A N/A N/A $1.6M0.0% $1.6M0.0% $1.6M0.0% $1.6M0.0% $1.6M
Total Liabilities $29.1M+0.4% $29.0M-0.5% $29.1M-5.2% $30.7M-9.9% $34.1M+0.6% $33.9M-11.8% $38.4M+87.9% $20.4M
Current Liabilities $28.9M+0.6% $28.8M-0.3% $28.9M-5.1% $30.4M-9.8% $33.7M+0.7% $33.5M-11.6% $37.9M+97.4% $19.2M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$21.7M-22.1% -$17.7M-11.8% -$15.9M+1.3% -$16.1M-0.2% -$16.1M-21.7% -$13.2M-0.7% -$13.1M-316.0% $6.1M
Retained Earnings -$67.2M-6.2% -$63.3M-3.0% -$61.5M-1.8% -$60.4M-1.8% -$59.3M-13.4% -$52.3M-6.2% -$49.3M-75.1% -$28.1M

SYSX Cash Flow Statement

Metric Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21 Q3'21
Operating Cash Flow -$25K-124.3% $103K+117.0% -$605K+53.4% -$1.3M+28.3% -$1.8M+52.7% -$3.8M-43.2% -$2.7M+42.7% -$4.7M
Capital Expenditures N/A N/A N/A N/A N/A N/A -$1.0M-1545.8% $72K
Free Cash Flow N/A N/A N/A N/A N/A N/A -$3.7M+21.7% -$4.7M
Investing Cash Flow N/A N/A $96K-91.0% $1.1M-14.3% $1.2M-69.7% $4.1M+548.1% -$917K-469.6% -$161K
Financing Cash Flow N/A N/A N/A N/A N/A N/A -$18K-100.2% $9.0M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

SYSX Financial Ratios

Metric Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22 Q4'21 Q3'21
Gross Margin N/A N/A N/A N/A N/A N/A N/A -1.8%
Operating Margin -167.4%-111.8pp -55.6%-46.5pp -9.0%+30.1pp -39.1%+41.6pp -80.7%-29.4pp -51.3%+17.6pp -68.9%+133.3pp -202.3%
Net Margin -239.8%-194.1pp -45.7%-25.0pp -20.7%+10.3pp -31.0%+166.9pp -197.9%-137.7pp -60.2%+599.5pp -659.7%-407.8pp -251.9%
Return on Equity N/A N/A N/A N/A N/A N/A N/A -77.5%
Return on Assets -52.7%-36.1pp -16.6%-8.4pp -8.3%-0.9pp -7.3%+31.5pp -38.9%-24.2pp -14.7%+64.0pp -78.7%-61.0pp -17.7%
Current Ratio 0.18-0.1 0.31-0.1 0.37 N/A N/A 0.32-0.2 0.54+0.1 0.45
Debt-to-Equity -1.34+0.3 -1.63+0.2 -1.83+0.1 -1.91+0.2 -2.12+0.4 -2.57+0.4 -2.93-6.3 3.37
FCF Margin N/A N/A N/A N/A N/A N/A -123.2%+131.0pp -254.1%

Note: Shareholder equity is negative (-$15.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.37), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Sysorex (SYSX) reported $17.3M in total revenue for fiscal year 2022. This represents a 108.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Sysorex (SYSX) revenue grew by 108.6% year-over-year, from $8.3M to $17.3M in fiscal year 2022.

No, Sysorex (SYSX) reported a net income of -$12.2M in fiscal year 2022, with a net profit margin of -70.4%.

Sysorex (SYSX) reported diluted earnings per share of $-0.01 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sysorex (SYSX) had EBITDA of -$6.7M in fiscal year 2022, measuring earnings before interest, taxes, depreciation, and amortization.

Sysorex (SYSX) had an operating margin of -42.0% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

Sysorex (SYSX) had a net profit margin of -70.4% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.

Sysorex (SYSX) generated -$7.5M in operating cash flow during fiscal year 2022, representing cash generated from core business activities.

Sysorex (SYSX) had $13.2M in total assets as of fiscal year 2022, including both current and long-term assets.

Sysorex (SYSX) had 2M shares outstanding as of fiscal year 2022.

Sysorex (SYSX) had a current ratio of 0.37 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.

Sysorex (SYSX) had a debt-to-equity ratio of -1.83 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sysorex (SYSX) had a return on assets of -92.1% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2022 data, Sysorex (SYSX) had $29K in cash against an annual operating cash burn of $7.5M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Sysorex (SYSX) has negative shareholder equity of -$15.9M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Sysorex (SYSX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sysorex (SYSX) has an earnings quality ratio of 0.62x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sysorex (SYSX) has an interest coverage ratio of -51.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Sysorex (SYSX) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top